BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 2830146)

  • 1. Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.
    Lu J; Piper SJ; Zhao P; Miller LJ; Wootten D; Sexton PM
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.
    Harmar AJ; Fahrenkrug J; Gozes I; Laburthe M; May V; Pisegna JR; Vaudry D; Vaudry H; Waschek JA; Said SI
    Br J Pharmacol; 2012 May; 166(1):4-17. PubMed ID: 22289055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of 125I-vasoactive intestinal polypeptide binding sites in arteries of the hamster seminal vesicle following castration.
    Barroso CP; Afonso F; Castro Caldas M; Pinho M; Mata L; Gulbenkian S
    Histochem J; 1999 May; 31(5):271-6. PubMed ID: 10461861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
    Harmar AJ; Arimura A; Gozes I; Journot L; Laburthe M; Pisegna JR; Rawlings SR; Robberecht P; Said SI; Sreedharan SP; Wank SA; Waschek JA
    Pharmacol Rev; 1998 Jun; 50(2):265-70. PubMed ID: 9647867
    [No Abstract]   [Full Text] [Related]  

  • 5. Predominant expression of type II vasoactive intestinal peptide receptors by human T lymphoblastoma cells: transduction of both Ca2+ and cyclic AMP signals.
    Xia M; Sreedharan SP; Goetzl EJ
    J Clin Immunol; 1996 Jan; 16(1):21-30. PubMed ID: 8926282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A VIP hybrid antagonist: from developmental neurobiology to clinical applications.
    Gozes I; Fridkin M; Brenneman DE
    Cell Mol Neurobiol; 1995 Dec; 15(6):675-87. PubMed ID: 8719036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines.
    Lerner UH; Lundberg P; Ransjö M; Persson P; Håkanson R
    Calcif Tissue Int; 1994 Apr; 54(4):284-9. PubMed ID: 7914821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phorbol ester TPA stimulates the expression of functional beta-adrenoceptors in human T lymphoblasts Molt 3.
    Robberecht P; De Neef P; Buscail L; Christophe J
    Biochem J; 1989 Aug; 261(3):959-63. PubMed ID: 2552994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helodermin and islet hormone release in isolated rat pancreas.
    Fehmann HC; Göke R; Göke B; Eissele R; Arnold R
    Int J Pancreatol; 1991 May; 8(4):289-303. PubMed ID: 1686442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide receptors in pancreas and liver. Structure-function relationship.
    Christophe J; Svoboda M; Waelbroeck M; Winand J; Robberecht P
    Ann N Y Acad Sci; 1988; 527():238-56. PubMed ID: 2839079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector mechanisms of peptides of the VIP family.
    Christophe J; Svoboda M; Lambert M; Waelbroeck M; Winand J; Dehaye JP; Vandermeers-Piret MC; Vandermeers A; Robberecht P
    Peptides; 1986; 7 Suppl 1():101-7. PubMed ID: 3018687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new type of functional VIP receptor has an affinity for helodermin in human SUP-T1 lymphoblasts.
    Robberecht P; Waelbroeck M; De Neef P; Tastenoy M; Gourlet P; Cogniaux J; Christophe J
    FEBS Lett; 1988 Feb; 228(2):351-5. PubMed ID: 2830146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes.
    Robberecht P; De Neef P; Gourlet P; Cauvin A; Coy DH; Christophe J
    Regul Pept; 1989; 26(2):117-26. PubMed ID: 2552509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
    Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
    Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP receptors in human SUP-T1 lymphoblasts.
    Christophe J; Cauvin A; Vervisch E; Buscail L; Damien C; Abello J; Gourlet P; Robberecht P
    Digestion; 1990; 46 Suppl 2():148-55. PubMed ID: 1979777
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.